| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |